Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota

AimTo investigate the treating effect of Yiqi-Bushen-Tiaozhi (YBT) recipe on nonalcoholic steatohepatitis (NASH) mice, determine whether the outcome was associated with gut microbiota, and clarify the regulating mechanism.MethodsNASH mice were induced by high-fat and high-fructose diets (HFFD). In t...

Full description

Bibliographic Details
Main Authors: Junbin Yan, Yunmeng Nie, Yuan Liu, Jingya Li, Liyan Wu, Zhiyun Chen, Beihui He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.824597/full
_version_ 1828380637889822720
author Junbin Yan
Junbin Yan
Yunmeng Nie
Yuan Liu
Yuan Liu
Jingya Li
Jingya Li
Liyan Wu
Zhiyun Chen
Zhiyun Chen
Beihui He
Beihui He
author_facet Junbin Yan
Junbin Yan
Yunmeng Nie
Yuan Liu
Yuan Liu
Jingya Li
Jingya Li
Liyan Wu
Zhiyun Chen
Zhiyun Chen
Beihui He
Beihui He
author_sort Junbin Yan
collection DOAJ
description AimTo investigate the treating effect of Yiqi-Bushen-Tiaozhi (YBT) recipe on nonalcoholic steatohepatitis (NASH) mice, determine whether the outcome was associated with gut microbiota, and clarify the regulating mechanism.MethodsNASH mice were induced by high-fat and high-fructose diets (HFFD). In the fifth week, mice in the YBT group were orally administrated YBT (22.12g·kg-1·d-1) daily for 12 weeks. Fresh stool of mice was collected at the 16th week for fecal 16S rDNA analysis. Hepatic pathology and biochemical indicators were used to reflect the improvement of YBT on hepatic inflammation and lipid metabolism in NASH mice. Quantitative real-time PCR (qRT-PCR) was used to verify the results of PICRUSt analysis.ResultsResults of the pathological and biochemical index showed that YBT could improve NASH mice. Compared with improving inflammation and hepatocyte damage, YBT may be more focused on enhancing metabolic disorders in mice, such as increasing HDL-c level. The diversity and richness of the gut microbiota of NASH mice induced by HFFD are significantly different from the normal control (NC) group. After YBT treatment, the diversity and richness of the mice microbiota will be increased to similar NC mice. Intestinimonas, Acetatifactor, Alistipes, Intestinimonas, Acetatifactor, and Alistipes have the most significant changes in the class level. PICRUSt analysis was performed to predict genomic functions based on the 16S rDNA results and reference sequencing. The efficacy of YBT in the treatment of NASH can be achieved by regulating the diversity and richness of gut microbiota. PICRUSt analysis results showed that the most relevant function of the microbiota construction variations is α- Linolenic acid (ALA) metabolism. Results of qRT-PCR showed significant differences between groups in the expression of Fatty acid desaturase 1 (FADS1), Fatty acid desaturase 2 (FADS2), Acyl-CoA Oxidase 1 (ACOX1), and Acyl-CoA Oxidase 2 (ACOX2) related to ALA metabolism. The expression of the above genes will be inhibited in the liver and small intestine of the HFFD group mice, and the expression can be restored after YBT treatment.ConclusionYBT could treat NASH mice by improving the diversity and richness of gut microbiota and further the improvement of ALA metabolism.
first_indexed 2024-12-10T04:00:33Z
format Article
id doaj.art-e5416d05cded463cb08a93ae3c5596ac
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-10T04:00:33Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-e5416d05cded463cb08a93ae3c5596ac2022-12-22T02:02:59ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-04-011210.3389/fcimb.2022.824597824597Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut MicrobiotaJunbin Yan0Junbin Yan1Yunmeng Nie2Yuan Liu3Yuan Liu4Jingya Li5Jingya Li6Liyan Wu7Zhiyun Chen8Zhiyun Chen9Beihui He10Beihui He11The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe Second Central Laboratory, Key Lab of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe Second Central Laboratory, Key Lab of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe Second Central Laboratory, Key Lab of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Gastroenterology, Tongde Hospital of Zhejiang Province, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe Second Central Laboratory, Key Lab of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaThe Second Central Laboratory, Key Lab of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaAimTo investigate the treating effect of Yiqi-Bushen-Tiaozhi (YBT) recipe on nonalcoholic steatohepatitis (NASH) mice, determine whether the outcome was associated with gut microbiota, and clarify the regulating mechanism.MethodsNASH mice were induced by high-fat and high-fructose diets (HFFD). In the fifth week, mice in the YBT group were orally administrated YBT (22.12g·kg-1·d-1) daily for 12 weeks. Fresh stool of mice was collected at the 16th week for fecal 16S rDNA analysis. Hepatic pathology and biochemical indicators were used to reflect the improvement of YBT on hepatic inflammation and lipid metabolism in NASH mice. Quantitative real-time PCR (qRT-PCR) was used to verify the results of PICRUSt analysis.ResultsResults of the pathological and biochemical index showed that YBT could improve NASH mice. Compared with improving inflammation and hepatocyte damage, YBT may be more focused on enhancing metabolic disorders in mice, such as increasing HDL-c level. The diversity and richness of the gut microbiota of NASH mice induced by HFFD are significantly different from the normal control (NC) group. After YBT treatment, the diversity and richness of the mice microbiota will be increased to similar NC mice. Intestinimonas, Acetatifactor, Alistipes, Intestinimonas, Acetatifactor, and Alistipes have the most significant changes in the class level. PICRUSt analysis was performed to predict genomic functions based on the 16S rDNA results and reference sequencing. The efficacy of YBT in the treatment of NASH can be achieved by regulating the diversity and richness of gut microbiota. PICRUSt analysis results showed that the most relevant function of the microbiota construction variations is α- Linolenic acid (ALA) metabolism. Results of qRT-PCR showed significant differences between groups in the expression of Fatty acid desaturase 1 (FADS1), Fatty acid desaturase 2 (FADS2), Acyl-CoA Oxidase 1 (ACOX1), and Acyl-CoA Oxidase 2 (ACOX2) related to ALA metabolism. The expression of the above genes will be inhibited in the liver and small intestine of the HFFD group mice, and the expression can be restored after YBT treatment.ConclusionYBT could treat NASH mice by improving the diversity and richness of gut microbiota and further the improvement of ALA metabolism.https://www.frontiersin.org/articles/10.3389/fcimb.2022.824597/fullnonalcoholic steatohepatitisYiqi-Bushen-Tiaozhi recipeTraditional Chinese Medicinegut microbiotaα-Linolenic acidlipid metabolism
spellingShingle Junbin Yan
Junbin Yan
Yunmeng Nie
Yuan Liu
Yuan Liu
Jingya Li
Jingya Li
Liyan Wu
Zhiyun Chen
Zhiyun Chen
Beihui He
Beihui He
Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
Frontiers in Cellular and Infection Microbiology
nonalcoholic steatohepatitis
Yiqi-Bushen-Tiaozhi recipe
Traditional Chinese Medicine
gut microbiota
α-Linolenic acidlipid metabolism
title Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
title_full Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
title_fullStr Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
title_full_unstemmed Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
title_short Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
title_sort yiqi bushen tiaozhi recipe attenuated high fat and high fructose diet induced nonalcoholic steatohepatitis in mice via gut microbiota
topic nonalcoholic steatohepatitis
Yiqi-Bushen-Tiaozhi recipe
Traditional Chinese Medicine
gut microbiota
α-Linolenic acidlipid metabolism
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.824597/full
work_keys_str_mv AT junbinyan yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT junbinyan yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT yunmengnie yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT yuanliu yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT yuanliu yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT jingyali yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT jingyali yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT liyanwu yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT zhiyunchen yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT zhiyunchen yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT beihuihe yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota
AT beihuihe yiqibushentiaozhirecipeattenuatedhighfatandhighfructosedietinducednonalcoholicsteatohepatitisinmiceviagutmicrobiota